Elite: read structure, select intervals, replay history
Explore linked evidence, interval analysis and replay in a complete case without signing in. Then try your own stock. Elite includes StockFlow from Plus and Radar research from Premium.
StockInvestingSI.com is a stock research and market information website: daily market briefings, company analysis, industry chains, and watchlist tools that help you follow stocks and understand market moves. Browse the homepage and selected research without signing in; create a free account to save your watchlist and keep up with the companies you follow. Operated by WealthAI Limited.
Research pages updated daily: S&P 500 and Nasdaq 100 stock analysis, industry supply-chain maps, and investment theme leaderboards, plus beginner guides. Start with a stock you follow: explore its analysis, understand its supply chain, and track related investment themes.
Today's close · Friday, October 30, 2026
Of 3779 stocks today, 8 are worth a closer look.
LLY: Doubler score 68 · Positive 3- and 6-month returns · Above the 200-day average · More estimate upgrades than downgrades. XOM: Doubler score 66 · Positive 3- and 6-month returns · Above the 200-day average · Forward EPS estimate increased · More estimate upgrades than downgrades. REGN: Doubler score 66 · Positive 3- and 6-month returns · Above the 200-day average · Forward EPS estimate increased · More estimate upgrades than downgrades.
Doubler score 66 · Positive 3- and 6-month returns · Above the 200-day average · Forward EPS estimate increased · More estimate upgrades than downgrades
REGNRegeneron Pharmaceuticals+13.3%
Doubler score 66 · Positive 3- and 6-month returns · Above the 200-day average · Forward EPS estimate increased · More estimate upgrades than downgrades
GDYNGrid Dynamics+40.8%
Doubler score 78 · Positive 3- and 6-month returns · Above the 200-day average
CVXChevron+1.8%
Doubler score 66 · Positive 3- and 6-month returns · Above the 200-day average · Forward EPS estimate increased · More estimate upgrades than downgrades
AZNAstraZeneca+7.0%
Doubler score 62 · Positive 3- and 6-month returns · Above the 200-day average
SPOTSpotify Technology+6.5%
Doubler score 62 · Positive 3- and 6-month returns · Above the 200-day average
CDNACareDx+22.2%
Doubler score 78 · Positive 3- and 6-month returns · Above the 200-day average · More estimate upgrades than downgrades